首先第一步,打开BC省政府的官方网站申请注册:https://www2.gov.bc.ca/gov/content/covid-19/vaccine/register?bcgovtm=20210311_GCPE_Vizeum_COVID___Google_Search_BCGOV_EN_BC__Text#register (BC省政府官网截图) 在网页最下面,找到“我需要帮助(I need help)”一栏,点击“我在其他省份或国家接种了一针...
www2.gov.bc.ca/vaccinec 个人健康码 出生日期 接种疫苗日期 如果是已经注册的同学,进入后,可以直接通过BC Service Card App登陆,电脑端用户需要在手机上匹配Compare Code,手机端用户可以直接通过手机App授权登陆。 验证完成后,就可以获得疫苗卡啦!打完一针,两针以及没有注册的同学会获得不一样的疫苗卡。 目前二维码...
1、科兴新冠疫苗（SinoVac CoronaVac Vero Cell）2、国药众爱可维新冠疫苗（SinoPharm-Beijing BBIBP-CorV 或 BBIBP-CorV）3、康希诺克威莎新冠疫苗（Convidecia或CanSinoBio Ad5-nCoV）BC省疫苗卡申请 一、登陆官网，网址为：https://www2.gov.bc.ca/gov/content/covid-19/vaccine/register?bcgovtm=20210311_GCP...
一、登陆官网,网址为: https://www2.gov.bc.ca/gov/content/covid-19/vaccine/register?bcgovtm=20210311_GCPE_Vizeum_COVID___Google_Search_BCGOV_EN_BC__Text#register 二、将网页下拉到底部,找到“I need help”(我需要帮助) 点击“I got dose one or two in another province or country”(我在...
Covid-19 Vaccine 1、医保卡(MSP)注册 Personal Health Number 线上注册正式开放,全程只需5分钟: 注册时需要提供以下信息: 姓名 生日 邮编 医保卡号 一个有效的邮箱或者可以接受短信的手机号 医保卡号是在医保卡背后的那一串数字: 2、没有医保卡号可以通过电话注册 Phone Number ...
BEIJING, Feb. 21 (Xinhua) -- The number of COVID-19 vaccine doses administered on the Chinese mainland had reached over 3.08 billion on Sunday, growing by about 3.92 million from the day before, data from the National Health Commission showed Monday.■...
Since the first cases of coronavirus were identified at the start of last year, pharmaceutical companies have raced at unprecedented speed to develop a safe and effective vaccine to help stop the spread of Covid-19. In total there are now more than 230 vaccine candidates, according to the Wor...
COVID-19 pandemic and the precautions to follow. Finally, we also highlighted the limitations which would benefit future endeavours in establishing well-planned and sustainable CPR training programs for the public. Therefore, regardless of the existing COVID-19 pandemic, BCPR must be emphasised to ...
就在昨日,知名医学期刊Vaccine发表了一项由新加坡学者发起的研究。注意,该研究既不是中国学者开展的研究,更不是科兴自己做的研究。 新加坡初始使用的为全球最大、且盈利能力最强的新冠疫苗制造商——辉瑞生产的mRNA疫苗。但当局从2021年下半年开始发现了mRNA疫苗的局限性——一些...
BEIJING, June 16 (Xinhua) -- A China-developed mRNA COVID-19 vaccine as a third booster dose has been shown in human trials to be safe and able to induce an immune response against the Omicron variant. AWcorna, previously known as ARCoV, which encodes the receptor-binding domain of SARS...